Apria's COPD Treatment
We Make it Easier on You
With COPD (Chronic Obstructive Pulmonary Disease), treatment is a daily chore. But we do everything we can to make it easier on you. We tailor treatment to you to match your medical and lifestyle needs and provide you with 24/7 support every day of the year.
Medications can help people in the early stages of COPD control the symptoms and reduce exacerbations. The Apria COPD Care Program has a full range of COPD medicines along with complimentary overnight delivery. How many retail pharmacies do you know that deliver this level of service?
Convenient Pharmacy Services
- Convenient overnight delivery to new patients
- Advanced patient refill reminders
- 24/7 pharmacy support
Nebulized Therapy Effectiveness
Because there is no special technique or coordination required,1 a nebulizer may be a simpler, easier-to-use drug delivery system to those who do not gain optimal benefit from dry powder inhalers or metered dose inhalers. One of the main advantages of a small volume nebulizer is that the delivery of doses occurs over 60 to 90 breaths, rather than in just one or two inhalations. This means a single ineffective breath will not decrease the effectiveness of the treatment.2
For people in need of oxygen, Apria offers one of the most robust long-term oxygen therapy programs available, including a travel and relocation program.
Travel Program Covering All 50 States
- Oxygen system delivery for travel
- Oxygen system delivery and pick-up at destination
- 24/7 On-Call Clinical Support
Genetic Screening Test and Treatment
It is recommended that all people with COPD be tested for AAT Deficiency (Alpha-1 Antitripsyn Deficiency, also called Genetic Emphysema or Genetic COPD), according to the American Thoracic Society and European Respiratory Society.3 AAT Deficiency can lead to irreversible and progressive damage of lung tissue, which is why it is important to get treatment. The screening is a simple blood test.
The Apria COPD Care Program can help facilitate screening and provides treatments to patients diagnosed with AAT Deficiency.
- American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with AAT deficiency. Am J Respir Crit Care Med. 2003; 168:818-900.
- Rau, JL. Respiratory Care Pharmacology: Administration of Aerosolized Agents. Mosby; 6th edition; 2002: 43.
- American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. Am J Respir Crit Care Med. 2003 Oct 1; 168(7): 818-900.